Aussie Biotech Biota Completes Phase II Trials for Relenza Follow-On; Phase III To Be Conducted In Japan, Taiwan, Hong Kong and Korea

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.